EUVIMEDEUVIMED entdecken
Open Access

Prothrombin Complex Concentrate vs Conservative Management in ICH Associated With Direct Oral Anticoagulants

Bonaventure Ip, Sangqi Pan, Zhong Yuan, Trista Hung, Ho Ko, Xinyi Leng, Yuying Liu, Shuang Li, Sing Yau Lee, Cyrus Cheng, Howard Chan, Vincent Mok und 8 weitere

JAMA Network Open · 2024

DOI: 10.1001/jamanetworkopen.2023.54916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2024. Verfasst von Bonaventure Ip und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Therapeutics, Faculty of Medicine, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR. Hauptthemen laut MEDLINE: Conservative Treatment, Hemostatics, Blood Coagulation Factors. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Intracerebral hemorrhage (ICH) associated with direct oral anticoagulant (DOAC) use carries extremely high morbidity and mortality. The clinical effectiveness of hemostatic therapy is unclear.

Objective

To compare the clinical and radiological outcomes of DOAC-associated ICH treated with prothrombin complex concentrate (PCC) vs conservative management. Design, Setting, and Participants In this population-based, propensity score–weighted retrospective cohort study, patients who developed DOAC-associated ICH from January 1, 2016, to December 31, 2021, in Hong Kong were identified. The outcomes of patients who received 25 to 50 IU/kg PCC with those who received no hemostatic agents were compared. Data were analyzed from May 1, 2022, to June 30, 2023. Main Outcomes and Measures The primary outcome was modified Rankin scale of 0 to 3 or returning to baseline functional status at 3 months. Secondary outcomes were mortality at 90 days, in-hospital mortality, and hematoma expansion. Weighted logistic regression was performed to evaluate the association of PCC with study outcomes. In unweighted logistic regression models, factors associated with good neurological outcome and hematoma expansion in DOAC-associated ICH were identified.

Results

A total of 232 patients with DOAC-associated ICH, with a mean (SD) age of 77.2 (9.3) years and 101 (44%) female patients, were included. Among these, 116 (50%) received conservative treatment and 102 (44%) received PCC. Overall, 74 patients (31%) patients had good neurological recovery and 92 (39%) died within 90 days. Median (IQR) baseline hematoma volume was 21.7 mL (3.6-66.1 mL). Compared with conservative management, PCC was not associated with improved neurological recovery (adjusted odds ratio [aOR], 0.62; 95% CI, 0.33-1.16; P = .14), mortality at 90 days (aOR, 1.03; 95% CI, 0.70-1.53; P = .88), in-hospital mortality (aOR, 1.11; 95% CI, 0.69-1.79; P = .66), or reduced hematoma expansion (aOR, 0.94; 95% CI, 0.38-2.31; P = .90). Higher baseline hematoma volume, lower Glasgow coma scale, and intraventricular hemorrhage were associated with lower odds of good neurological outcome but not hematoma expansion. Conclusions and Relevance In this cohort study, Chinese patients with DOAC-associated ICH had large baseline hematoma volumes and high rates of mortality and functional disability. PCC treatment was not associated with improved functional outcome, hematoma expansion, or mortality. Further studies on novel hemostatic agents as well as neurosurgical and adjunctive medical therapies are needed to identify the best management algorithm for DOAC-associated ICH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Conservative TreatmentHemostaticsBlood Coagulation FactorsHumansFemaleAgedMaleCohort StudiesRetrospective StudiesFactor IXCerebral HemorrhageHematomaAnticoagulants

Substanzen

prothrombin complex concentratesFactor IXHemostaticsAnticoagulantsBlood Coagulation Factors

Autor:innen und Institutionen

  • Department of Medicine and Therapeutics, Faculty of Medicine, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR.
  • Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR.
  • Department of Computer Science and Engineering, The Chinese University of Hong Kong, Hong Kong SAR.
  • Department of Electrical Engineering, The City University of Hong Kong, Hong Kong SAR.
  • Department of Diagnostic Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong SAR.
  • Department of Neurology, Inselspital University Hospital Bern and University of Bern, Bern, Switzerland.

Zitieren

APA

Ip, B., Pan, S., Yuan, Z., Hung, T., Ko, H., Leng, X., Liu, Y., Li, S., Lee, S. Y., Cheng, C., Chan, H., Mok, V., Soo, Y., Wu, X., Lui, L. T., Chan, R., Abrigo, J., Dou, Q., Seiffge, D., & Leung, T. (2024). Prothrombin Complex Concentrate vs Conservative Management in ICH Associated With Direct Oral Anticoagulants. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.54916

Vancouver

Ip B, Pan S, Yuan Z, Hung T, Ko H, Leng X, et al. Prothrombin Complex Concentrate vs Conservative Management in ICH Associated With Direct Oral Anticoagulants. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2023.54916

BibTeX
@article{Ip2024,
  author = {Ip, Bonaventure and Pan, Sangqi and Yuan, Zhong and Hung, Trista and Ko, Ho and Leng, Xinyi and Liu, Yuying and Li, Shuang and Lee, Sing Yau and Cheng, Cyrus and Chan, Howard and Mok, Vincent and Soo, Yannie and Wu, Xiaoli and Lui, Leong Ting and Chan, Rosa and Abrigo, Jill and Dou, Qi and Seiffge, David and Leung, Thomas},
  title = {Prothrombin Complex Concentrate vs Conservative Management in ICH Associated With Direct Oral Anticoagulants},
  journal = {JAMA Network Open},
  year = {2024},
  doi = {10.1001/jamanetworkopen.2023.54916}
}
Kostenlos starten →